InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Davis Matthew W.. Director active across 1 company, notably Aquestive Therapeutics, Inc.. Aggregated, 2 disclosures have been recorded. Activity tracked since 10 November 2025. The latest transaction was filed on 9 March 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations